Patent · US Active

QSOX1 as an anti-neoplastic drug target

US8946186B2 · kind B2 · utility

2Cited by
3References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2013
Grant dateFeb 3, 2015
Priority date—
Expiry dateMar 20, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y108/03002
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides methods for tumor treatment by administering an inhibitor of quiescin sulfhydryl oxidase 1 (QSOX1), compositions comprising such inhibitors, and methods for identifying such inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.